---
figid: PMC6818007__JAH3-8-e012875-g003
figtitle: VEGF (vascular endothelial growth factor)‐angiogenesis signaling and cell
  cycle regulation pathways
organisms:
- NA
pmcid: PMC6818007
filename: JAH3-8-e012875-g003.jpg
figlink: /pmc/articles/PMC6818007/figure/jah34407-fig-0003/
number: F3
caption: VEGF (vascular endothelial growth factor)‐angiogenesis signaling and cell
  cycle regulation pathways. VEGF signaling is a growth factor pathway to stimulate
  vasculogenesis and angiogenesis. A, MAPK/ERK signaling regulates cell proliferation.
  B, AKT/PI3K signaling is related to protein synthesis and cell cycle signaling.
  Locations of anti–P‐ERK and anti–P‐S6 used in IHC studies are also shown in the
  pathway (white arrows). C, Damage‐signaling pathway. AKT/PI3K signaling inhibits
  apoptosis, senescence, and cell cycle arrest through inhibition of FOXO, which in
  turn positively regulates p21 and p27 activity.
papertitle: POT1 and Damage Response Malfunction Trigger Acquisition of Somatic Activating
  Mutations in the VEGF Pathway in Cardiac Angiosarcomas.
reftext: Oriol Calvete, et al. J Am Heart Assoc. 2019 Sep 17;8(18):e012875.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9578459
figid_alias: PMC6818007__F3
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC6818007__F3
ndex: b6226ad0-dee4-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6818007__JAH3-8-e012875-g003.html
  '@type': Dataset
  description: VEGF (vascular endothelial growth factor)‐angiogenesis signaling and
    cell cycle regulation pathways. VEGF signaling is a growth factor pathway to stimulate
    vasculogenesis and angiogenesis. A, MAPK/ERK signaling regulates cell proliferation.
    B, AKT/PI3K signaling is related to protein synthesis and cell cycle signaling.
    Locations of anti–P‐ERK and anti–P‐S6 used in IHC studies are also shown in the
    pathway (white arrows). C, Damage‐signaling pathway. AKT/PI3K signaling inhibits
    apoptosis, senescence, and cell cycle arrest through inhibition of FOXO, which
    in turn positively regulates p21 and p27 activity.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - VEGFA
  - KDR
  - PDGFRB
  - PDGFRA
  - FGFR1
  - FGFR2
  - FGFR3
  - FGFR4
  - FGFRL1
  - EGFR
  - POT1
  - SRC
  - FGR
  - FYN
  - YES1
  - PI3
  - XYLT2
  - SOS1
  - SOS2
  - PLCG1
  - NRG2
  - AKT1
  - AKT2
  - AKT3
  - MYC
  - KRAS
  - HRAS
  - NRAS
  - ITGAV
  - FOXO1
  - FOXO3
  - FOXO4
  - FOXO6
  - IFI27
  - PSMD9
  - ZNRD2
  - DCTN6
  - TMED7
  - H3P23
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - TP53
  - CDKN1A
  - TCEAL1
  - NSG1
  - H3P16
  - TAS2R63P
  - MTOR
  - ATM
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - CDK1
  - CDK2
  - ATR
  - ANTXR1
  - MMAB
  - SERPINA2
  - EPHB2
  - RICTOR
  - CDC25C
  - RASGRF1
  - CDC25A
  - CDC25B
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - CHEK1
  - CHEK2
  - Cancer
  - Lung cancer
  - Melanoma
  - Noonan syndrome
---
